title: Atypical neuroleptic malignant syndrome in an adolescent.
authors.affiliation: Psychiatry Department, Ruppert Health Center, University of Toledo Medical Center, Toledo, Ohio 43614, USA.
authors.forename: Alina R
authors.initials: AR
authors.lastname: Rais
authors.forename: Sanford
authors.initials: S
authors.lastname: Kimmel
authors.forename: Niranjan
authors.initials: N
authors.lastname: Shrestha
authors.forename: Theodor B
authors.initials: TB
authors.lastname: Rais
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Coffey
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D000077152:Olanzapine; D010259:Paranoid Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000069348:Quetiapine Fumarate
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D000077152:Olanzapine; D002746:Chlorpromazine